Inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) indicate systemic inflammation, which is often elevated in CKD patients and contributes to disease progression. This evidence concerns the gene IL6 and chronic kidney disease.